Table 1 Patient and tumour characteristics
ACE | PE | Total | P -value | |
|---|---|---|---|---|
No. of patients | 139 | 141 | 280 | |
Male/female | 67/72 | 75/66 | 142/138 | 0.47 |
Median age, years (range) | 66 (38–81) | 65 (39–89) | 0.95 | |
Stage | ||||
Limited | 84 (60) | 81 (57) | 165 | 0.65 |
Metastatic | 54 (39) | 60 (43) | 112 | |
Limited stage, good PS, normal LDH | 21% | 29% | ||
Prognostic score (MS) | ||||
0 | 31 (22) | 41 (29) | 72 | |
1 | 63 (45) | 56 (40) | 119 | |
2 | 45 (33) | 40 (28) | 85 | |
3 | 0 (0) | 4 (3) | 4 | 0.1 |
Performance status (WHO) | ||||
0 | 19 (14) | 20 (14) | 39 | |
1 | 82 (59) | 83 (59) | 165 | |
2 | 36 (26) | 37 (26) | 73 | |
3 | 1 (1) | 1 (1) | 2 |
